Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT04971304
Eligibility Criteria:
Inclusion Criteria:
* Patients age 20 or older
* Diagnosis of lung, breast, colon, ovarian, pancreatic, testicular, cervical, uterine, or NHL cancer
* Beginning intermediate or high neutropenia risk chemotherapy
Exclusion Criteria:
* One inpatient or two outpatient cancer diagnoses at least 30 days apart in the 183 days prior to the Index Date for cancer different from enrolling cancer diagnosis
* Any of the following in 183 days prior to Index Date:
* Any chemotherapy or G-CSF product receipt
* 2\< medical claims at least 30 days apart for a skilled nursing facility or hospice care
* 2\< diagnoses/procedure codes at least 1 day apart for cancer-related radiotherapy, bone marrow or stem cell transplant, diagnosis of HIV/AIDS, severe hepatic disease, chronic kidney disease, or any non-oncology related neutropenia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT04971304
Study Brief:
Protocol Section:
NCT04971304